93 2274 (Amoxicillin and clavulanate potassium 500 mg / 125 mg)
Pill imprint 93 2274 has been identified as Amoxicillin and clavulanate potassium 500 mg / 125 mg.
Amoxicillin/clavulanate is used in the treatment of bacterial infection; urinary tract infection; strep throat; bronchitis; aspiration pneumonia (and more), and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy. Amoxicillin/clavulanate 500 mg / 125 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 93 2274
- 500 mg / 125 mg
- 20.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Beta-lactamase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (50 mPa.s)
polyethylene glycol 8000
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|54569-5470||A S Medication Solutions LLC (repackager)|
|54868-4743||Physicians Total Care Inc (repackager)|
|68115-0386||Dispensexpress Inc (repackager)|
|23490-5074||Palmetto State Pharmaceuticals Inc (repackager)|
|10544-0331||Blenheim Pharmacal Inc (repackager)|
|18837-0357||Innoviant Pharmacy Inc (repackager)|
|68071-0063||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about amoxicillin/clavulanate
- Amoxicillin and Clavulanate
- Amoxicillin/clavulanate chewable tablets
- Amoxicillin/clavulanate extended-release tablets
- Amoxicillin/clavulanate suspension
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.